Egypt Edition 
MENA+ Edition 
UAE Edition 
Saudi Edition 
AI + Innovation (MENA) 
Infrastructure 
Rameda Pharma reports 36% drop in net profits
EARNINGS WATCH- Rameda Pharma’s net profits dropped 36% y-o-y in FY2019 to EGP 82.4 mn, down from EGP 129 mn…
Earnings watch: Rameda Pharma, Obour Land
EARNINGS WATCH- Rameda pre-tax profits fall 12% in 2019: Rameda Pharma made pre-tax profits of EGP 225 mn in FY2019,…
Rameda Pharma plans expansion to 10 new Gulf and African markets
Rameda Pharma is planning to expand sales to 10 new Gulf and African markets in the medium term as part…
Rameda among “best-placed” to capitalize on Egyptian pharma sector’s growth potential
Rameda among “best-placed” to capitalize on Egyptian pharmasector’s growth potential, sees >50% upside to shares: Egypt’s pharmamarket has significant potential…
Emerald expects to raise EGP 203 mn in January IPO
IPO WATCH- Emerald expects to raise EGP 203 mn from upcoming IPO: Real estate investment firm Emeraldis expecting to raise…
Rameda Pharma dip in EGX debut
Rameda Pharma dip in EGX debut: Rameda Pharma shares edged down 4.7% in light trading on the EGX debut yesterday.…
What we’re tracking on 12 December 2019
It’s a relatively quiet morning heading into the weekend. It is also a little early for the holiday-season news slowdown,…
What we’re tracking on 11 December 2019
Today will largely be shaped by how two IPOs will fare in their market debuts. Here at home, Rameda Pharma…
Something went wrong. Please refresh the page and/or try again.